Viewing StudyNCT00022672



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022672
Status: COMPLETED
Last Update Posted: 2013-06-13
First Post: 2001-08-10

Brief Title: A Study to Evaluate the Efficacy and Safety of Herceptin Trastuzumab in Combination With Arimidex Anastrozole an Aromatase Inhibitor Compared to Arimidex Alone in Patients With Metastatic Breast Cancer
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-01
Start Date Type: None
Primary Completion Date: 2009-10
Primary Completion Date Type: ACTUAL
Completion Date: 2009-10
Completion Date Type: ACTUAL
First Submit Date: 2001-08-10
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-06-13
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-06-07
Last Update Post Date: 2013-06-13
Last Update Post Date Type: ESTIMATED